Clinical presentations of parvovirus B19 infection

被引:2
|
作者
Servey, Jessica T.
Reamy, Brian V.
Hodge, Joshua
机构
[1] Family Med Clin, Travis AFB, CA 94535 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Although most persons with parvovirus B19 infection are asymptomatic or have mild, nonspecific, cold-like symptoms, several clinical conditions have been linked to the virus. Parvovirus B19 usually infects children and causes the classic "slapped-cheek" rash of erythema infectiosum (fifth disease). The virus is highly infectious and spreads mainly through respiratory droplets. By the time the rash appears, the virus is no longer infectious. The virus also may cause acute or persistent arthropathy and papular, purpuric eruptions on the hands and feet ("gloves and socks" syndrome) in adults. Parvovirus B19 infection can trigger an acute cessation of red blood cell production, causing transient aplastic crisis, chronic red cell aplasia, hydrops fetalis, or congenital anemia. This is even more likely in patients with illnesses that have already shortened the lifespan of erythrocytes (e.g., iron deficiency anemia, human immunodeficiency virus, sickle cell disease, thalassemia, spherocytosis). A clinical diagnosis can be made without laboratory confirmation if erythema infectiosum is present. If laboratory confirmation is needed, serum immunoglobulin M testing is recommended for immunocompetent patients; viral DNA testing is recommended for patients in aplastic crisis and for those who are immunocompromised. Treatment is usually supportive, although some patients may require transfusions or intravenous immune globulin therapy. Most patients recover completely.
引用
收藏
页码:373 / 376
页数:4
相关论文
共 50 条
  • [1] Human parvovirus B19 infection in children: Uncommon clinical presentations
    Barash, J
    Dushnitzky, D
    Sthoeger, D
    Bardenstein, R
    Barak, Y
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (10): : 763 - 765
  • [2] Clinical Presentations of Parvovirus B19: A Case Series
    Tricella, Chiara
    Pagliani, Costanza
    Quatrale, Antonia
    Poretti, Giulia
    Caiazzo, Roberta
    Coppola, Crescenzo
    Lorenzo, Marc Garcia
    Valentino, Maria Sole
    Giacomet, Vania
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2025, 44 (01) : e18 - e21
  • [3] Clinical impact of parvovirus B19 infection
    Jordan, J.
    HAEMOPHILIA, 2010, 16 : 64 - 64
  • [4] Clinical aspects of parvovirus B19 infection
    Broliden, K.
    Tolfvenstam, T.
    Norbeck, O.
    JOURNAL OF INTERNAL MEDICINE, 2006, 260 (04) : 285 - 304
  • [5] Parvovirus B19 infection
    Chen, S
    Howard, O
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (06): : 598 - 598
  • [6] Infection with parvovirus B19
    Stanley J. Naides
    Current Infectious Disease Reports, 1999, 1 (3) : 273 - 278
  • [7] Parvovirus B19 infection
    Tolfvenstam, Thomas
    Broliden, Kristina
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2009, 14 (04): : 218 - 221
  • [8] Parvovirus B19 infection
    Kerr, JR
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (01) : 10 - 29
  • [9] Parvovirus B19 Infection
    Mende, Marika
    Sockel, Katja
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24): : 2361 - 2361
  • [10] Parvovirus B19 infection and its clinical picture
    Dudina, K. R.
    Znoiko, O. O.
    Yuschuk, N. D.
    TERAPEVTICHESKII ARKHIV, 2007, 79 (11) : 75 - 78